FILIPPI, MASSIMO
 Distribuzione geografica
Continente #
AS - Asia 51.876
EU - Europa 50.134
NA - Nord America 42.878
SA - Sud America 12.818
Continente sconosciuto - Info sul continente non disponibili 3.470
AF - Africa 1.078
OC - Oceania 144
AN - Antartide 1
Totale 162.399
Nazione #
US - Stati Uniti d'America 40.529
RU - Federazione Russa 29.265
SG - Singapore 19.523
CN - Cina 15.634
BR - Brasile 10.443
HK - Hong Kong 6.379
IT - Italia 5.970
VN - Vietnam 4.835
SE - Svezia 4.691
FR - Francia 2.692
DE - Germania 1.875
BD - Bangladesh 1.444
GB - Regno Unito 1.237
CA - Canada 1.077
AR - Argentina 959
IN - India 947
FI - Finlandia 828
RO - Romania 756
MX - Messico 594
NL - Olanda 529
ID - Indonesia 412
AT - Austria 409
EC - Ecuador 409
ZA - Sudafrica 387
TR - Turchia 361
PL - Polonia 360
IQ - Iraq 345
ES - Italia 340
JP - Giappone 319
IE - Irlanda 283
CO - Colombia 222
PY - Paraguay 190
VE - Venezuela 181
PK - Pakistan 176
SA - Arabia Saudita 167
CL - Cile 166
UA - Ucraina 163
MA - Marocco 157
IR - Iran 152
JM - Giamaica 142
UZ - Uzbekistan 134
LT - Lituania 130
AU - Australia 129
MY - Malesia 128
AE - Emirati Arabi Uniti 116
PE - Perù 116
TN - Tunisia 109
CR - Costa Rica 103
EG - Egitto 94
CH - Svizzera 91
KE - Kenya 91
DZ - Algeria 87
UY - Uruguay 82
NP - Nepal 76
PH - Filippine 74
BE - Belgio 72
PT - Portogallo 70
IL - Israele 67
JO - Giordania 60
KR - Corea 58
HN - Honduras 57
TT - Trinidad e Tobago 57
KZ - Kazakistan 54
CZ - Repubblica Ceca 53
DO - Repubblica Dominicana 53
AZ - Azerbaigian 50
NI - Nicaragua 46
AL - Albania 45
BO - Bolivia 43
TW - Taiwan 43
SV - El Salvador 40
OM - Oman 39
TH - Thailandia 39
GT - Guatemala 38
DK - Danimarca 37
MD - Moldavia 37
BB - Barbados 35
LB - Libano 33
PA - Panama 32
ET - Etiopia 31
GR - Grecia 28
NO - Norvegia 28
KW - Kuwait 26
PS - Palestinian Territory 24
KG - Kirghizistan 23
SN - Senegal 23
BG - Bulgaria 21
CY - Cipro 21
BH - Bahrain 20
PR - Porto Rico 20
EU - Europa 19
BY - Bielorussia 18
KH - Cambogia 17
RS - Serbia 17
BA - Bosnia-Erzegovina 16
GE - Georgia 16
NG - Nigeria 16
SK - Slovacchia (Repubblica Slovacca) 15
AM - Armenia 13
CI - Costa d'Avorio 11
Totale 158.689
Città #
Singapore 8.424
Dallas 8.110
Moscow 6.653
Hong Kong 6.282
Ashburn 4.664
San Jose 4.663
Council Bluffs 3.065
Shanghai 2.543
Hefei 2.502
Lauterbourg 2.156
Lawrence 1.864
Princeton 1.862
Ho Chi Minh City 1.765
Beijing 1.588
Milan 1.372
New York 1.352
Hanoi 1.086
Los Angeles 957
São Paulo 937
Santa Clara 788
Rome 548
Helsinki 476
Munich 456
Nuremberg 447
Boardman 431
Orem 377
Rio de Janeiro 330
Montreal 322
Phoenix 299
Warsaw 289
Dublin 271
Chicago 266
Brooklyn 264
Denver 256
Tokyo 246
Chennai 244
Frankfurt am Main 242
Atlanta 233
London 233
Mexico City 229
Guangzhou 223
Da Nang 219
Johannesburg 216
Houston 210
Belo Horizonte 200
Stockholm 196
Curitiba 194
Toronto 189
Vienna 187
Poplar 185
Brasília 183
The Dalles 177
Lappeenranta 176
Manchester 175
Washington 174
Amsterdam 171
Boston 171
Seattle 170
Pune 167
Haiphong 159
Naples 157
Turku 155
Porto Alegre 150
Tianjin 146
Biên Hòa 140
Buffalo 140
Guayaquil 137
Ankara 131
Shenzhen 130
Salvador 127
Turin 123
Campinas 121
Quito 120
Baghdad 117
Tashkent 114
Dhaka 109
Mumbai 109
Bologna 107
Fortaleza 101
Hangzhou 101
Philadelphia 98
Florence 97
Charlotte 94
Brescia 90
Ribeirão Preto 90
Sydney 89
Hải Dương 87
San José 85
Guarulhos 84
Omaha 84
Kingston 82
Miami 80
Thái Bình 80
Paris 79
San Francisco 79
Buenos Aires 77
Nairobi 77
Genoa 76
Kuala Lumpur 75
Las Vegas 75
Totale 77.047
Nome #
10kin1day: A bottom-up neuroimaging initiative 2.297
Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria 399
Erratum to: Multiple sclerosis (Nature Reviews Disease Primers, (2018), 4, 1, (43), 10.1038/s41572-018-0041-4) 366
The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study 355
Multi-Center 3D CNN for Parkinson's disease diagnosis and prognosis using clinical and T1-weighted MRI data 297
Epidural electrical stimulation facilitates motor recovery in spinal cord injury involving the conus medullaris: A case study 279
A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis 278
Long-term effectiveness and safety of ocrelizumab: a single-centre real-world study 273
Awareness impairment in Alzheimer's disease and frontotemporal dementia: a systematic MRI review 272
A window into the mind-brain-body interplay: Development of diagnostic, prognostic biomarkers, and rehabilitation strategies in functional motor disorders 265
Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access 250
High-frequency epidural electrical stimulation reduces spasticity and facilitates walking recovery in patients with spinal cord injury 244
Stool Glial Fibrillary Acidic Protein Is Elevated in Progressive Multiple Sclerosis 234
Using the Progression Independent of Relapse Activity Framework to Unveil the Pathobiological Foundations of Multiple Sclerosis 223
Sporadic Fatal Insomnia presenting with agrypnia excitata and rapidly progressive dementia: a case report 216
Amyloid-Related Imaging Abnormalities and β-Amyloid-Targeting Antibodies: A Systematic Review 202
The brief repeatable battery of neuropsychological tests (BRB-N) version a: update of Italian normative data from the Italian Neuroimaging Network Initiative (INNI) 200
A common marker of affect recognition dysfunction in the FTD spectrum of disorders 193
Functional MRI of the Spinal Cord 191
Ocrelizumab extended-interval dosing in multiple sclerosis during SARS-CoV-2 pandemic: a real-world experience 190
A multicentric investigation of the diagnostic accuracy of cortical lesions and central vein sign in multiple sclerosis 189
2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis 186
A novel scoring approach to identify responders to erenumab in clinical practice 185
Application of Deep-Learning to NMOSD and Seronegative Patients with Limited NMOSD Manifestations 180
Action Observation and Motor Imagery Improve Dual Task in Parkinson's Disease: A Clinical/fMRI Study 179
Real-word application of the AT(N) classification and disease-modifying treatment eligibility in a hospital-based cohort 178
Functional correlates of intelligence quotient and cognitive abilities vary according to maturation in pediatric MS 177
Resting State Functional Connectivity Changes of the Pons in Migraine Patients: A Cross-Sectional and Longitudinal Study 176
XGBoost vs. TabPFN in Neuroimaging Machine Learning-based analysis 176
Extent and characteristics of carotid plaques and brain parenchymal loss in asymptomatic patients with no indication for revascularization 175
Resting State Effective Connectivity Abnormalities of the Papez Circuit Contribute to Explain Worse Cognitive Performances in Multiple Sclerosis Patients (P1-1.Virtual) 175
MRI biomarkers of freezing of gait development in Parkinson's disease 174
Clinical and neuroanatomical characterization of the semantic behavioral variant of frontotemporal dementia in a multicenter Italian cohort 174
Alterations of brain structural MRI are associated with outcome of surgical treatment in trigeminal neuralgia 174
Diagnostic accuracy of automated Lumipulse plasma pTau-217 in Alzheimer’s disease: a real-world study 174
A comparison of MR imaging with fast-FLAIR, HASTE-FLAIR, and EPI-FLAIR sequences in the assessment of patients with multiple sclerosis 173
A Deep Learning Approach to Predicting Disease Progression in Multiple Sclerosis Using Magnetic Resonance Imaging 172
A functional MRI study of cortical activations associated with object manipulation in patients with multiple sclerosis 170
Selecting structural MRI predictors of cognitive status in MS patients through a machine learning approach applied to a large multicenter MS population 168
The HTT gene influences plasma neurofilament light chain and brain metabolism in prodromal Alzheimer’s disease 167
Efficacy and safety of anti-CGRP monoclonal antibodies for chronic migraine prophylaxis in patients treated with botulinum toxin A: A prospective monocentric study 167
Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci 164
Cognitive and MRI profile in primary and secondary progressive multiple sclerosis 164
Assessing treatment response to oral drugs for multiple sclerosis in real world setting: a MAGNIMS study 164
Favorable long-term cognitive outcomes following recurrent ARIA linked to amyloid-lowering therapies: two cases 164
A functional magnetic resonance imaging study of patients with secondary progressive multiple sclerosis 162
Functional Connectivity From Disease Epicenters in Frontotemporal Dementia 161
Characterizing 1-Year Development of Cervical Cord Atrophy Across Different Ms Phenotypes: A Voxel-Wise, Multicenter Analysis 161
2.5-Year changes of connectivity dynamism are relevant for physical and cognitive deterioration in multiple sclerosis 160
Impact of Multiple Sclerosis on Cognitive Aging: A Multicenter Study 160
Glymphatic system impairment in multiple sclerosis: relation with brain damage and disability 160
Correction to: Pharmacogenomics of clinical response to Natalizumab in multiple sclerosis: a genome-wide multi-centric association study (Journal of Neurology, (2024), 271, 11, (7250-7263), 10.1007/s00415-024-12608-6) 159
A conventional and magnetization transfer MRI study of the cervical cord in patients with MS 159
A functional MRI study of cortical activations associated with object manipulation in patients with MS 158
Dual-task gait training improves cognition and resting-state functional connectivity in Parkinson’s disease with postural instability and gait disorders 157
Recognizing Leber’s Hereditary Optic Neuropathy to avoid delayed diagnosis and misdiagnosis 156
A 24-week prospective, multicenter, real-world study on eptinezumab’s effectiveness and safety in migraine prevention (EMBRACE II) 156
A composite score to predict short-term disease activity in patients with relapsing-remitting MS 156
A comparison between the sensitivities of 3-mm and 5-mm thick serial brain MRI for detecting lesion volume changes in patients with multiple sclerosis 156
Association of the Cervical Canal Area With Disability and Progression in People With Multiple Sclerosis 155
A comprehensive update on neuroimaging endpoints in amyotrophic lateral sclerosis 154
Stratify and ImmunoWELL JCV tests performances in a real-world multiple sclerosis cohort: possible clinical implications of biosimilar Natalizumab use 154
250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study 153
Cardiorespiratory fitness and free-living physical activity are not associated with cognition in persons with progressive multiple sclerosis: baseline analyses from the COGEX study 153
A brain MRI study of different types of chronic-progressive multiple sclerosis 150
The association between cognition and motor performance is beyond structural damage in relapsing–remitting multiple sclerosis 150
A Fully Automatic Method to Segment Choroid Plexuses in Multiple Sclerosis Using Conventional MRI Sequences 149
Connected Speech Alterations and Progression in Patients With Primary Progressive Aphasia Variants 149
Effects of atidarsagene autotemcel gene therapy on peripheral nerves in late-infantile metachromatic leukodystrophy 149
Dynamic functional connectivity of thalamic sub-regions shows divegent patterns in multiple sclerosis phenotypes 149
Gray matter damage predicts the accumulation of disability 13 years later in MS. 149
Cognitive, EEG, and MRI features of COVID-19 survivors: a 10-month study 149
Expanded and independent validation of the NoMoFA scale for Parkinson’s disease: the Italian version 149
Correction to: Sporadic Fatal Insomnia presenting with agrypnia excitata and rapidly progressive dementia: a case report (Journal of Neurology, (2023), 10.1007/s00415-023-11605-5) 148
A 3-year diffusion tensor MRI study of grey matter damage progression during the earliest clinical stage of MS 147
A brain magnetization transfer MRI study with a clinical follow up of about four years in patients with clinically isolated syndromes suggestive of multiple sclerosis 147
Refractory anti-NMDAR encephalitis successfully treated with bortezomib and associated movements disorders controlled with tramadol: a case report with literature review 146
Neural correlates of bradykinesia in Parkinson’s disease: a kinematic and functional MRI study 145
Tumefactive Demyelination in MOG Ab-Associated Disease, Multiple Sclerosis, and AQP-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder 144
Current perspectives on the diagnosis and management of fatigue in multiple sclerosis 142
Cognitive phenotypes in multiple sclerosis: mapping the spectrum of impairment 142
A comparison of multimodal evoked potentials, nuclear magnetic resonance imaging and CSF profile for the diagnosis of multiple sclerosis. 142
Neurofilament light chain as a biological marker for amyotrophic lateral sclerosis: a meta-analysis study 142
A 3-Year Magnetic Resonance Imaging Study of Cortical Lesions in Relapse-Onset Multiple Sclerosis 141
Clinical Features and Biomarkers to Differentiate Primary and Amyotrophic Lateral Sclerosis in Patients With an Upper Motor Neuron Syndrome 140
Phenotypes and clinical subgroups in vestibular migraine: a cross-sectional study with cluster analysis 140
Cerebro-cerebellar motor networks in clinical subtypes of Parkinson's disease 139
Use of the combination of spirometry, arterial blood gas analysis and overnight oximetry to predict the outcomes of patients affected by motor neuron disease: The Milan-Torin respiratory score (Mi-To-RS) 138
DNA Methylation in the Anti-Mullerian Hormone Gene and the Risk of Disease Activity in Multiple Sclerosis 138
A comparison of the sensitivity of monthly unenhanced and enhanced MRI techniques in detecting new multiple sclerosis lesions 138
Gamma Knife radiosurgery as primary treatment of low-grade brainstem gliomas: A systematic review and metanalysis of current evidence and predictive factors 138
A diffusion tensor MRI study of cervical cord damage in benign and secondary progressive multiple sclerosis patients 137
Correspondence among gray matter atrophy and atlas-based neurotransmitter maps is clinically relevant in multiple sclerosis 135
fMRI of the Sensorimotor System 134
Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis 134
A novel GRN mutation in an Italian patient with non-fluent variant of primary progressive aphasia at onset: a longitudinal case report 134
A diffusion tensor magnetic resonance imaging study of brain tissue from patients with migraine 134
A 1-year serial clinical and MRI study of primary progressive multiple sclerosis 134
Immune-mediated colitis: A class effect with anti-CD2O agents used to treat MS? 133
A functional MRI study of cortical activations associated with object manipulation in patients with multiple sclerosis 132
Totale 19.666
Categoria #
all - tutte 1.003.781
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.003.781


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.381 0 29 26 619 45 99 118 79 88 82 89 107
2022/20239.416 4.200 1.746 598 52 119 1.017 313 506 394 80 152 239
2023/20245.317 258 272 457 470 382 972 279 514 123 326 402 862
2024/202531.466 3.538 643 571 673 796 2.196 3.940 2.534 5.807 4.686 3.277 2.805
2025/2026104.462 7.249 8.621 9.175 14.916 6.956 2.984 9.095 7.781 26.379 5.829 2.770 2.707
2026/20279.291 3.692 5.599 0 0 0 0 0 0 0 0 0 0
Totale 162.399